Clinical Trial on Remdesivir Ongoing at Einstein and Montefiore

Barry Zingman, M.D., discusses the clinical trial he is leading at Einstein and Montefiore to evaluate the experimental drug remdesivir to treat COVID-19. Dr Zingman is professor of medicine at Einstein and clinical director, infectious diseases, in the Moses division of Montefiore Health System.

Additional coverage of Dr. Zingman on COVID-19 includes: FoxNews, SpectrumNY1 , Scientific American, ABC7NY, LoHud, The Riverdale Press, and Norwood News